Matthew C Kapusta
CIK 1536290 · CEO, Managing Director · last filed 2026-03-06
Matthew C Kapusta is a CEO, Managing Director who has filed 79 SEC Form 4 insider transactions across 3 companies since 2012. The most recent filing, for QURE, was dated Mar 6, 2026. Across all open-market trades the lifetime net is −$38.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $18.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$18.62M
3
79
-$38.08M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QURE | CEO, Managing Director | 675,239 | $27.57 | $18.62M | -$38.09M | 66 | 2026-03-06 |
| Decibel Therapeutics, Inc. (DBTX) Delisted | Director | 0 | $4.91 | $0 | $0 | 2 | 2023-09-25 |
| ANGIODYNAMICS INC (ANGO.V) Delisted | SVP, Business Development | 30,062 | — | — | $11.4K | 11 | 2014-11-19 |
Recent Filings
79 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-06 | QURE | Mixed | +56,019 | -$132.1K | EDGAR |
| 2026-03-04 | QURE | Sell (S) | −34,437 | -$342.6K | EDGAR |
| 2026-02-27 | QURE | Sell (S) | −12,378 | -$295.3K | EDGAR |
| 2025-09-26 | QURE | Mixed | — | -$7.91M | EDGAR |
| 2025-03-05 | QURE | Mixed | +70,659 | -$291.6K | EDGAR |
| 2025-02-27 | QURE | Mixed | −17,120 | -$362.0K | EDGAR |
| 2024-12-12 | QURE | Mixed | — | -$32.0K | EDGAR |
| 2024-12-10 | QURE | Mixed | +7,076 | -$26.1K | EDGAR |
| 2024-03-05 | QURE | Grant (A) | +150,000 | $0 | EDGAR |
| 2024-02-28 | QURE | Sell (S) | −27,904 | -$177.2K | EDGAR |